NCT03679026

Brief Summary

Cognition and locomotion are two human abilities controlled by the brain. Their decline is highly prevalent with aging, and is greater than the simple sum of their respective prevalence, suggesting a complex age-related interplay between cognition and locomotion. Recently, a systematic review and meta-analysis has provided evidence that poor gait performance predicts dementia and, in particular, has demonstrated that "motoric cognitive risk" (MCR) syndrome, which has been described in cognitively healthy individuals and combines subjective cognitive complaint with objective slow gait speed, is a pre-dementia syndrome. The uniqueness of "motoric cognitive risk" (MCR)syndrome is that it does not rely on a complex evaluation or laboratory investigations. Thus, it is easy to apply in population-based settings. The overall objective of the proposal is to examine the epidemiology of the newly reported "motoric cognitive risk" (MCR) syndrome, in the Quebec population using the database of the NuAge study.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,461

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 22, 2017

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 20, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2021

Completed
3.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2024

Completed
Last Updated

April 5, 2024

Status Verified

April 1, 2024

Enrollment Period

4 years

First QC Date

August 21, 2018

Last Update Submit

April 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cardio-vascular risk factors and diseases assessed using reported health condition

    medical history

    1 day

Secondary Outcomes (16)

  • Cardio-vascular risk factors and diseases assessed using physical examination: BMI

    1 day

  • Cardio-vascular risk factors and diseases assessed using physical examination: HW ratio

    1 day

  • Cardio-vascular risk factors and diseases assessed using physical examination: blood pressure

    1 day

  • Disability and functional limitations

    1 day

  • Disability and functional limitations

    1 day

  • +11 more secondary outcomes

Study Arms (2)

CVRF

individuals with cardio-vascular risk factors and diseases

Other: Summarize of participants' characteristics using means and standard deviations or frequencies and percentages

WCVRF

individuals without cardio-vascular risk factors and diseases

Other: Summarize of participants' characteristics using means and standard deviations or frequencies and percentages

Interventions

Participants' baseline characteristics will be summarized using means and standard deviations or frequencies and percentages, as appropriate.

CVRFWCVRF

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals eligible for this study will be participants of the comprehensive Canadian Longitudinal Study on Aging (n=30,097). They are separated in four age groups (i.e.; 45-54, 54-64, 65-74 and 75-85). Each group will be divided in two subgroups: individuals with and without cardio-vascular risk factors and diseases.

You may qualify if:

  • Individuals eligible for this study will be participants of the NuAge study

You may not qualify if:

  • Individuals not eligible for the NuAge study
  • dementia
  • mobility disability
  • no information about cognitive complaint
  • no measure of walking speed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Location

MeSH Terms

Conditions

Cardiovascular DiseasesDementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Geriatrics

Study Record Dates

First Submitted

August 21, 2018

First Posted

September 20, 2018

Study Start

August 22, 2017

Primary Completion

August 21, 2021

Study Completion

December 21, 2024

Last Updated

April 5, 2024

Record last verified: 2024-04

Locations